Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial

  1. Douglas, P.S.
  2. Umbleja, T.
  3. Bloomfield, G.S.
  4. Fichtenbaum, C.J.
  5. Zanni, M.V.
  6. Overton, E.T.
  7. Fitch, K.V.
  8. Kileel, E.M.
  9. Aberg, J.A.
  10. Currier, J.
  11. Sponseller, C.A.
  12. Melbourne, K.
  13. Avihingsanon, A.
  14. Bustorff, F.
  15. Estrada, V.
  16. Ruxrungtham, K.
  17. Saumoy, M.
  18. Navar, A.M.
  19. Hoffmann, U.
  20. Ribaudo, H.J.
  21. Grinspoon, S.
Revue:
Clinical Infectious Diseases

ISSN: 1537-6591,  1058-4838

Année de publication: 2021

Volumen: 73

Número: 11

Pages: 2009-2022

Type: Article

DOI: 10.1093/CID/CIAB552 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus